SIRT6 controls healthy ageing by regulating genomic stability, oxidative stress, and glucose metabolism, and it is considered a promising target for age-associated diseases such as chronic inflammation, diseases associated with metabolic syndrome, obesity, and insulin resistant type-2 diabetes [3,4,5,6,7,8]. The gene discussed is SIRT6; the disease is obesity due to melanocortin 4 receptor deficiency.